Related Experiment Videos
Stimulant rebound: how common is it and what does it mean?
Gabrielle A Carlson1, Kevin L Kelly
1Department of Psychiatry and Behavioral Science, State University of New York at Stony Brook, Stony Brook, New York 11794-8790, USA.
Journal of Child and Adolescent Psychopharmacology
|July 26, 2003
Summary
Stimulant rebound, a behavioral worsening as medication wears off, affects 30% of hospitalized children. However, it rarely necessitates treatment discontinuation and lacks specific diagnostic significance for attention deficit hyperactivity disorder.
Area of Science:
- Child and Adolescent Psychiatry
- Pharmacology
- Behavioral Science
Background:
- Stimulant medications are frequently prescribed for attention deficit hyperactivity disorder (ADHD).
- A phenomenon known as stimulant rebound, characterized by behavioral deterioration as medication effects diminish, has been anecdotally reported.
- Understanding the prevalence and clinical impact of rebound is crucial for optimizing ADHD treatment.
Purpose of the Study:
- To investigate the incidence of stimulant-induced rebound in psychiatrically hospitalized children.
- To assess the clinical implications and necessity of treatment discontinuation due to rebound.
- To determine if rebound has any specific diagnostic significance.
Main Methods:
- A comparative observational study design was employed.
- Nurse observations were systematically recorded during evening and day shifts.
- Data were collected from 149 psychiatrically hospitalized children treated with short-acting stimulants, primarily methylphenidate, comparing medicated and non-medicated states.
Main Results:
- Behavioral deterioration consistent with rebound was observed in 30% of children receiving stimulant medication.
- Rebound was severe enough to warrant discontinuation of stimulant treatment in only 8.7% of cases.
- Children who experienced rebound did not exhibit clinically significant differences compared to those who did not.
Conclusions:
- Stimulant-induced rebound is a documented phenomenon in psychiatrically hospitalized children.
- The incidence of clinically significant rebound requiring treatment cessation is relatively low (less than 10%).
- Rebound does not appear to hold specific diagnostic significance for attention deficit hyperactivity disorder.